Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Mary Jeanne Kreek

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Living Beings

Concepts & Ideas

Drug Dose-Response Relationship

Anatomy

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
93
Ho, Ann
37
Zhou, Yan
34
LaForge, Steven
34
Schlussman, Stefan
32
Butelman, Eduardo
29
Yuferov, Vadim
22
Spangler, Rudolph
19
Borg, Lisa
16
Unterwald, EM
14
Maggos, CE
14
Ott, Jurg
13
Nielsen, David
13
Schluger, James
12
Zhang, Yong
10
Bart, Gavin

Sign-in to see all Coauthors

Publications

TOP 3
Fox Helen C; Hong Kwang-Ik A; Siedlarz Kristen M; Bergquist Keri; Anderson George; Kreek Mary Jeanne; Sinha Rajita
Sex-specific dissociations in autonomic and HPA responses to stress and cues in alcohol-dependent patients with cocaine abuse.
Levran O; Londono D; O'Hara K; Randesi M; Rotrosen J; Casadonte P; Linzy S; Ott J; Adelson M; Kreek M J
Heroin addiction in African Americans: a hypothesis-driven association study.
Reed Brian; Varon Jack; Chait Brian T; Kreek Mary Jeanne
Carbon dioxide-induced anesthesia results in a rapid increase in plasma levels of vasopressin.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Mary Jeanne Kreek (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Fox Helen C; Hong Kwang-Ik A; Siedlarz Kristen M; Bergquist Keri; Anderson George; Kreek Mary Jeanne; Sinha Rajita
Sex-specific dissociations in autonomic and HPA responses to stress and cues in alcohol-dependent patients with cocaine abuse.
Alcohol and alcoholism (Oxford, Oxfordshire) 2009;44(6):575-85.
2009: Levran O; Londono D; O'Hara K; Randesi M; Rotrosen J; Casadonte P; Linzy S; Ott J; Adelson M; Kreek M J
Heroin addiction in African Americans: a hypothesis-driven association study.
Genes, brain, and behavior 2009;8(5):531-40.
2009: Reed Brian; Varon Jack; Chait Brian T; Kreek Mary Jeanne
Carbon dioxide-induced anesthesia results in a rapid increase in plasma levels of vasopressin.
Endocrinology 2009;150(6):2934-9.
2009: Brady Kathleen T; McRae Aimee L; Moran-Santa Maria Megan M; DeSantis Stacia M; Simpson Annie N; Waldrop Angela E; Back Sudie E; Kreek Mary Jeanne
Response to corticotropin-releasing hormone infusion in cocaine-dependent individuals.
Archives of general psychiatry 2009;66(4):422-30.
2009: Leri Francesco; Zhou Yan; Goddard Benjamin; Levy AnneMarie; Jacklin Derek; Kreek Mary Jeanne
Steady-state methadone blocks cocaine seeking and cocaine-induced gene expression alterations in the rat brain.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2009;19(4):238-49.
2009: Yuferov Vadim; Ji Fei; Nielsen David A; Levran Orna; Ho Ann; Morgello Susan; Shi Ruijin; Ott Jurg; Kreek Mary Jeanne
A functional haplotype implicated in vulnerability to develop cocaine dependence is associated with reduced PDYN expression in human brain.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2009;34(5):1185-97.
2009: Zhang Yong; Picetti Roberto; Butelman Eduardo R; Schlussman Stefan D; Ho Ann; Kreek Mary Jeanne
Behavioral and neurochemical changes induced by oxycodone differ between adolescent and adult mice.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2009;34(4):912-22.
2009: Nielsen David A; Yuferov Vadim; Hamon Sara; Jackson Colin; Ho Ann; Ott Jurg; Kreek Mary Jeanne
Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2009;34(4):867-73.
2009: Lahita Robert G; Schaefer Robert A; Bradlow H Leon; Kreek Mary Jeanne
Clues to understanding the oxidation of estradiol in humans: effects of acute infectious hepatitis, autoimmune hepatitis, and chronic liver disease.
Annals of the New York Academy of Sciences 2009;1155():242-51.
2009: Maiya Rajani; Zhou Yan; Norris Erin H; Kreek Mary Jeanne; Strickland Sidney
Tissue plasminogen activator modulates the cellular and behavioral response to cocaine.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(6):1983-8.
2009: Kreek Mary Jeanne; Zhou Yan; Butelman Eduardo R; Levran Orna
Opiate and cocaine addiction: from bench to clinic and back to the bench.
Current opinion in pharmacology 2009;9(1):74-80.
2009: Butelman Eduardo R; Prisinzano Thomas E; Deng Haiteng; Rus Szymon; Kreek Mary Jeanne
Unconditioned behavioral effects of the powerful kappa-opioid hallucinogen salvinorin A in nonhuman primates: fast onset and entry into cerebrospinal fluid.
The Journal of pharmacology and experimental therapeutics 2009;328(2):588-97.
2009: Zhang Y; Landthaler M; Schlussman S D; Yuferov V; Ho A; Tuschl T; Kreek M J
Mu opioid receptor knockdown in the substantia nigra/ventral tegmental area by synthetic small interfering RNA blocks the rewarding and locomotor effects of heroin.
Neuroscience 2009;158(2):474-83.
2009: Kreek M J; Schlussman S D; Reed B; Zhang Y; Nielsen D A; Levran O; Zhou Y; Butelman E R
Bidirectional translational research: Progress in understanding addictive diseases.
Neuropharmacology 2009;56 Suppl 1():32-43.
2008: Devidze N; Zhou Y; Ho A; Zhang Q; Pfaff D W; Kreek M J
Steady-state methadone effect on generalized arousal in male and female mice.
Behavioral neuroscience 2008;122(6):1248-56.
2008: Butelman Eduardo R; Rus Szymon; Simpson Denise S; Wolf Angela; Prisinzano Thomas E; Kreek Mary Jeanne
The effects of herkinorin, the first mu-selective ligand from a salvinorin A-derived scaffold, in a neuroendocrine biomarker assay in nonhuman primates.
The Journal of pharmacology and experimental therapeutics 2008;327(1):154-60.
2008: Levran O; Londono D; O'Hara K; Nielsen D A; Peles E; Rotrosen J; Casadonte P; Linzy S; Randesi M; Ott J; Adelson M; Kreek M J
Genetic susceptibility to heroin addiction: a candidate gene association study.
Genes, brain, and behavior 2008;7(7):720-9.
2008: Lane Diane A; Lessard Andree A; Chan June; Colago Eric E O; Zhou Yan; Schlussman Stefan D; Kreek Mary Jeanne; Pickel Virginia M
Region-specific changes in the subcellular distribution of AMPA receptor GluR1 subunit in the rat ventral tegmental area after acute or chronic morphine administration.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2008;28(39):9670-81.
2008: Oosterhuis Bronson E; LaForge K Steven; Proudnikov Dmitri; Ho Ann; Nielsen David A; Gianotti Robert; Barral Sandra; Gordon Derek; Leal Suzanne M; Ott Jurg; Kreek Mary Jeanne
Catechol-O-methyltransferase (COMT) gene variants: possible association of the Val158Met variant with opiate addiction in Hispanic women.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2008;147B(6):793-8.
2008: Schlussman Stefan D; Zhang Yong; Hsu Nicole M; Allen Julia M; Ho Ann; Kreek Mary Jeanne
Heroin-induced locomotor activity and conditioned place preference in C57BL/6J and 129P3/J mice.
Neuroscience letters 2008;440(3):284-8.
2008: Levran Orna; O'Hara Kimberly; Peles Einat; Li Dawei; Barral Sandra; Ray Brenda; Borg Lisa; Ott Jurg; Adelson Miriam; Kreek Mary Jeanne
ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence.
Human molecular genetics 2008;17(14):2219-27.
2008: Zhou Y; Cui C-L; Schlussman S D; Choi J C; Ho A; Han J-S; Kreek M J
Effects of cocaine place conditioning, chronic escalating-dose "binge" pattern cocaine administration and acute withdrawal on orexin/hypocretin and preprodynorphin gene expressions in lateral hypothalamus of Fischer and Sprague-Dawley rats.
Neuroscience 2008;153(4):1225-34.
2008: Novick David M; Kreek Mary Jeanne
Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients.
Addiction (Abingdon, England) 2008;103(6):905-18.
2008: Back Sudie E; Waldrop Angela E; Saladin Michael E; Yeatts Sharon D; Simpson Annie; McRae Aimee L; Upadhyaya Himanshu P; Contini Sisson Regana; Spratt Eve G; Allen Julia; Kreek Mary Jeanne; Brady Kathleen T
Effects of gender and cigarette smoking on reactivity to psychological and pharmacological stress provocation.
Psychoneuroendocrinology 2008;33(5):560-8.
2008: Reed B; Bidlack J M; Chait B T; Kreek M J
Extracellular biotransformation of beta-endorphin in rat striatum and cerebrospinal fluid.
Journal of neuroendocrinology 2008;20(5):606-16.
2008: Proudnikov Dmitri; Hamon Sara; Ott Jurg; Kreek Mary Jeanne
Association of polymorphisms in the melanocortin receptor type 2 (MC2R, ACTH receptor) gene with heroin addiction.
Neuroscience letters 2008;435(3):234-9.
2008: Bart Gavin; Piccolo Paola; Zhang Linqi; Jacobson Ira; Schaefer Robert A; Kreek Mary Jeanne
Markers for hepatitis A, B and C in methadone maintained patients: an unexpectedly high co-infection with silent hepatitis B.
Addiction (Abingdon, England) 2008;103(4):681-6.
2008: Kreek M J
Role of a functional human gene polymorphism in stress responsivity and addictions.
Clinical pharmacology and therapeutics 2008;83(4):615-8.
2008: Glass Michael J; Lane Diane A; Colago Eric E O; Chan June; Schlussman Stefan D; Zhou Yan; Kreek Mary Jeanne; Pickel Virginia M
Chronic administration of morphine is associated with a decrease in surface AMPA GluR1 receptor subunit in dopamine D1 receptor expressing neurons in the shell and non-D1 receptor expressing neurons in the core of the rat nucleus accumbens.
Experimental neurology 2008;210(2):750-61.
2008: Nielsen D A; Ji F; Yuferov V; Ho A; Chen A; Levran O; Ott J; Kreek M J
Genotype patterns that contribute to increased risk for or protection from developing heroin addiction.
Molecular psychiatry 2008;13(4):417-28.
2008: Butelman Eduardo R; Reed Brian; Chait Brian T; Mandau Marek; Yuferov Vadim; Kreek Mary Jeanne
Limited effects of beta-endorphin compared to loperamide or fentanyl in a neuroendocrine biomarker assay in non-human primates.
Psychoneuroendocrinology 2008;33(3):292-304.
2008: Nielsen David A; Barral Sandra; Proudnikov Dmitri; Kellogg Scott; Ho Ann; Ott Jurg; Kreek Mary Jeanne
TPH2 and TPH1: association of variants and interactions with heroin addiction.
Behavior genetics 2008;38(2):133-50.
2008: Zhou Yan; Leri Francesco; Cummins Erin; Hoeschele Marisa; Kreek Mary Jeanne
Involvement of arginine vasopressin and V1b receptor in heroin withdrawal and heroin seeking precipitated by stress and by heroin.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(2):226-36.
2007: Kroslak Thomas; Laforge K Steven; Gianotti Robert J; Ho Ann; Nielsen David A; Kreek Mary Jeanne
The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor.
Journal of neurochemistry 2007;103(1):77-87.
2007: Bailey Alexis; Gianotti Robert; Ho Ann; Kreek Mary J
Downregulation of kappa-opioid receptors in basolateral amygdala and septum of rats withdrawn for 14 days from an escalating dose "binge" cocaine administration paradigm.
Synapse (New York, N.Y.) 2007;61(10):820-6.
2007: Novick David M; Kreek Mary Jeanne
Hepatitis C treatment, subcutaneous naltrexone implants, and methadone maintenance treatment.
Hepatology (Baltimore, Md.) 2007;46(3):951-2.
2007: Williams Tanya J; LaForge K Steven; Gordon Derek; Bart Gavin; Kellogg Scott; Ott Jurg; Kreek Mary Jeanne
Prodynorphin gene promoter repeat associated with cocaine/alcohol codependence.
Addiction biology 2007;12(3-4):496-502.
2007: Koob George; Kreek Mary Jeanne
Stress, dysregulation of drug reward pathways, and the transition to drug dependence.
The American journal of psychiatry 2007;164(8):1149-59.
2007: Kreek Mary Jeanne; LaForge K Steven
Stress responsivity, addiction, and a functional variant of the human mu-opioid receptor gene.
Molecular interventions 2007;7(2):74-8.
2007: Kuzmin Alexander; Kreek Mary Jeanne; Bakalkin Georgy; Liljequist Sture
The nociceptin/orphanin FQ receptor agonist Ro 64-6198 reduces alcohol self-administration and prevents relapse-like alcohol drinking.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2007;32(4):902-10.
2007: Peles Einat; Bodner Gershon; Kreek Mary Jeanne; Rados Vera; Adelson Miriam
Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study.
Addiction (Abingdon, England) 2007;102(2):289-300.
2007: Zhou Yan; Adomako-Mensah Johannes; Yuferov Vadim; Ho Ann; Zhang Jianhua; Xu Ming; Kreek Mary Jeanne
Effects of acute "binge" cocaine on mRNA levels of mu opioid receptor and neuropeptides in dopamine D1 or D3 receptor knockout mice.
Synapse (New York, N.Y.) 2007;61(1):50-9.
2007: Butelman Eduardo R; Mandau Marek; Tidgewell Kevin; Prisinzano Thomas E; Yuferov Vadim; Kreek Mary Jeanne
Effects of salvinorin A, a kappa-opioid hallucinogen, on a neuroendocrine biomarker assay in nonhuman primates with high kappa-receptor homology to humans.
The Journal of pharmacology and experimental therapeutics 2007;320(1):300-6.
2007: Kreek Mary Jeanne
Opioids, dopamine, stress, and the addictions.
Dialogues in clinical neuroscience 2007;9(4):363-78.
2007: Adelson Miriam; Peles Einat; Bodner Gershon; Kreek Mary Jeanne
Correlation between high methadone doses and methadone serum levels in methadone maintenance treatment (MMT) patients.
Journal of addictive diseases 2007;26(1):15-26.
2007: Nielsen David A; Leidner Marty; Haynes Chad; Krauthammer Michael; Kreek Mary Jeanne
The BiolAD-DB system : an informatics system for clinical and genetic data.
Molecular diagnosis & therapy 2007;11(1):15-9.
2006: Zhou Yan; Bendor Jacob; Hofmann Lauren; Randesi Matthew; Ho Ann; Kreek Mary Jeanne
Mu opioid receptor and orexin/hypocretin mRNA levels in the lateral hypothalamus and striatum are enhanced by morphine withdrawal.
The Journal of endocrinology 2006;191(1):137-45.
2006: Bart Gavin; LaForge K Steven; Borg Lisa; Lilly Charles; Ho Ann; Kreek Mary Jeanne
Altered levels of basal cortisol in healthy subjects with a 118G allele in exon 1 of the Mu opioid receptor gene.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(10):2313-7.
2006: Fox H C; Wilker E H; Kreek M J; Sinha R
Reliability of salivary cortisol assessments in cocaine dependent individuals.
Journal of psychopharmacology (Oxford, England) 2006;20(5):650-5.
2006: Leri Francesco; Zhou Yan; Goddard Benjamin; Cummins Erin; Kreek Mary Jeanne
Effects of high-dose methadone maintenance on cocaine place conditioning, cocaine self-administration, and mu-opioid receptor mRNA expression in the rat brain.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(7):1462-74.
2006: Kellogg Scott; Kreek Mary Jeanne
On blending practice and research: the search for commonalities in substance abuse treatment.
Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 2006;27(1-2):9-24.
2006: Fox Helen C; Garcia Miguel; Kemp Kathleen; Milivojevic Verica; Kreek Mary Jeanne; Sinha Rajita
Gender differences in cardiovascular and corticoadrenal response to stress and drug cues in cocaine dependent individuals.
Psychopharmacology 2006;185(3):348-57.
2006: Aouizerate Bruno; Ho Ann; Schluger James H; Perret Guillaume; Borg Lisa; Le Moal Michel; Piazza Pier V; Kreek Mary Jeanne
Glucocorticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: dose-response to dexamethasone suppression.
Addiction biology 2006;11(1):84-96.
2006: Zhang Y; Svenningsson P; Picetti R; Schlussman S D; Nairn A C; Ho A; Greengard P; Kreek M J
Cocaine self-administration in mice is inversely related to phosphorylation at Thr34 (protein kinase A site) and Ser130 (kinase CK1 site) of DARPP-32.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2006;26(10):2645-51.
2006: Sinha Rajita; Garcia Miguel; Paliwal Prashni; Kreek Mary Jeanne; Rounsaville Bruce J
Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes.
Archives of general psychiatry 2006;63(3):324-31.
2006: Proudnikov Dmitri; LaForge K Steven; Hofflich Heather; Levenstien Mark; Gordon Derek; Barral Sandra; Ott Jurg; Kreek Mary Jeanne
Association analysis of polymorphisms in serotonin 1B receptor (HTR1B) gene with heroin addiction: a comparison of molecular and statistically estimated haplotypes.
Pharmacogenetics and genomics 2006;16(1):25-36.
2006: Kellogg Scott; Melia Dorothy; Khuri Elizabeth; Lin Amy; Ho Ann; Kreek Mary Jeanne
Adolescent and young adult heroin patients: drug use and success in methadone maintenance treatment.
Journal of addictive diseases 2006;25(3):15-25.
2006: Galarneau David W; Teres Jedediah J; Leon Andrew C; Melia Dorothy; Lilly Charles; Kellogg Scott; Khuri Elizabeth; Kreek Mary Jeanne
Antidepressant treatment patterns in a novel methadone maintenance clinic targeting young adults an observational study.
Journal of addictive diseases 2006;25(2):47-52.
2006: Peles Einat; Kreek Mary Jeanne; Kellogg Scott; Adelson Miriam
High methadone dose significantly reduces cocaine use in methadone maintenance treatment (MMT) patients.
Journal of addictive diseases 2006;25(1):43-50.
2005: Schmidt Matthew D; Schmidt Mark S; Butelman Eduardo R; Harding Wayne W; Tidgewell Kevin; Murry Daryl J; Kreek Mary Jeanne; Prisinzano Thomas E
Pharmacokinetics of the plant-derived kappa-opioid hallucinogen salvinorin A in nonhuman primates.
Synapse (New York, N.Y.) 2005;58(3):208-10.
2005: Bart Gavin; Schluger James H; Borg Lisa; Ho Ann; Bidlack Jean M; Kreek Mary Jeanne
Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity?
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2005;30(12):2254-62.
2005: Kreek Mary Jeanne; Nielsen David A; Butelman Eduardo R; LaForge K Steven
Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction.
Nature neuroscience 2005;8(11):1450-7.
2005: Schlussman Stefan D; Zhou Yan; Bailey Alexis; Ho Ann; Kreek Mary Jeanne
Steady-dose and escalating-dose "binge" administration of cocaine alter expression of behavioral stereotypy and striatal preprodynorphin mRNA levels in rats.
Brain research bulletin 2005;67(3):169-75.
2005: Yuferov Vadim; Butelman Eduardo R; Kreek Mary J
Biological clock: biological clocks may modulate drug addiction.
European journal of human genetics : EJHG 2005;13(10):1101-3.
2005: Glass Michael J; Kruzich Paul J; Colago Eric E O; Kreek Mary Jeanne; Pickel Virginia M
Increased AMPA GluR1 receptor subunit labeling on the plasma membrane of dendrites in the basolateral amygdala of rats self-administering morphine.
Synapse (New York, N.Y.) 2005;58(1):1-12.
2005: Fox Helen C; Talih Makram; Malison Robert; Anderson George M; Kreek Mary Jeanne; Sinha Rajita
Frequency of recent cocaine and alcohol use affects drug craving and associated responses to stress and drug-related cues.
Psychoneuroendocrinology 2005;30(9):880-91.
2005: Bailey Alexis; Gianotti Robert; Ho Ann; Kreek Mary Jeanne
Persistent upregulation of mu-opioid, but not adenosine, receptors in brains of long-term withdrawn escalating dose "binge" cocaine-treated rats.
Synapse (New York, N.Y.) 2005;57(3):160-6.
2005: Bailey Alexis; Yuferov Vadim; Bendor Jacob; Schlussman Stefan D; Zhou Yan; Ho Ann; Kreek Mary Jeanne
Immediate withdrawal from chronic "binge" cocaine administration increases mu-opioid receptor mRNA levels in rat frontal cortex.
Brain research. Molecular brain research 2005;137(1-2):258-62.
2005: Zhang Yong; Butelman Eduardo R; Schlussman Stefan D; Ho Ann; Kreek Mary Jeanne
Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors.
Psychopharmacology 2005;179(3):551-8.
2005: Schmidt Mark S; Prisinzano Thomas E; Tidgewell Kevin; Harding Wayne; Butelman Eduardo R; Kreek Mary J; Murry Daryl J
Determination of Salvinorin A in body fluids by high performance liquid chromatography-atmospheric pressure chemical ionization.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2005;818(2):221-5.
2005: Yuferov Vadim; Nielsen David; Butelman Eduardo; Kreek Mary Jeanne
Microarray studies of psychostimulant-induced changes in gene expression.
Addiction biology 2005;10(1):101-18.
2005: Kreek Mary Jeanne; Bart Gavin; Lilly Charles; LaForge K Steven; Nielsen David A
Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments.
Pharmacological reviews 2005;57(1):1-26.
2005: Bart Gavin; Kreek Mary Jeanne; Ott Jurg; LaForge K Steven; Proudnikov Dmitri; Pollak Lotta; Heilig Markus
Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2005;30(2):417-22.
2005: Kellogg Scott H; Burns Marylee; Coleman Peter; Stitzer Maxine; Wale Joyce B; Kreek Mary Jeanne
Something of value: the introduction of contingency management interventions into the New York City Health and Hospital Addiction Treatment Service.
Journal of substance abuse treatment 2005;28(1):57-65.
2005: Yuferov Vadim; Bart Gavin; Kreek Mary Jeanne
Clock reset for alcoholism.
Nature medicine 2005;11(1):23-4.
2005: Zhou Y; Bendor J T; Yuferov V; Schlussman S D; Ho A; Kreek M J
Amygdalar vasopressin mRNA increases in acute cocaine withdrawal: evidence for opioid receptor modulation.
Neuroscience 2005;134(4):1391-7.
2004: Yuferov Vadim; Fussell David; LaForge K Steven; Nielsen David A; Gordon Derek; Ho Ann; Leal Suzanne M; Ott Jurg; Kreek Mary Jeanne
Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction.
Pharmacogenetics 2004;14(12):793-804.
2004: Proudnikov Dmitri; LaForge K Steven; Kreek Mary Jeanne
High-throughput molecular haplotype analysis (allelic assignment) of single-nucleotide polymorphisms by fluorescent polymerase chain reaction.
Analytical biochemistry 2004;335(1):165-7.
2004: Zhou Yan; Spangler Rudolph; Yuferov Vadim P; Schlussmann Stefan D; Ho Ann; Kreek Mary Jeanne
Effects of selective D1- or D2-like dopamine receptor antagonists with acute "binge" pattern cocaine on corticotropin-releasing hormone and proopiomelanocortin mRNA levels in the hypothalamus.
Brain research. Molecular brain research 2004;130(1-2):61-7.
2004: Butelman Eduardo R; Harris Todd J; Kreek Mary Jeanne
Antiallodynic effects of loperamide and fentanyl against topical capsaicin-induced allodynia in unanesthetized primates.
The Journal of pharmacology and experimental therapeutics 2004;311(1):155-63.
2004: Glass Michael J; Kruzich Paul J; Kreek Mary Jeanne; Pickel Virginia M
Decreased plasma membrane targeting of NMDA-NR1 receptor subunit in dendrites of medial nucleus tractus solitarius neurons in rats self-administering morphine.
Synapse (New York, N.Y.) 2004;53(4):191-201.
2004: Kreek Mary Jeanne; Jones Reese; Kleber Herbert D; Kosten Thomas; O'Brien Charles
NIDA's commitment to tackling drug abuse.
Nature 2004;430(7003):965.
2004: Mantsch John R; Yuferov Vadim; Mathieu-Kia Anne-Marie; Ho Ann; Kreek Mary Jeanne
Effects of extended access to high versus low cocaine doses on self-administration, cocaine-induced reinstatement and brain mRNA levels in rats.
Psychopharmacology 2004;175(1):26-36.
2004: Berrettini Wade; Bierut Laura; Crowley Thomas J; Cubells Joseph F; Frascella Joseph; Gelernter Joel; Hewitt John K; Kreek Mary Jeanne; Lachman Herb; Leppert Mark; Li Ming D; Lachman Herb; Leppert Mark; Li Ming D; Madden Pamela; Miner Cindy; Pollock Jonathan D; Pomerleau Ovide; Rice John P; Rutter Joni L; Shurtleff David; Swan Gary E; Tischfield Jay A; Tsuang Ming; Uhl George R; Vanyukov Michael; Volkow Nora D; Wanke Kay
Setting priorities for genomic research.
Science (New York, N.Y.) 2004;304(5676):1445-7; author reply 1445-7.
2004: Bart G; Heilig M; LaForge K S; Pollak L; Leal S M; Ott J; Kreek M J
Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden.
Molecular psychiatry 2004;9(6):547-9.
2004: Zhang Yong; Butelman Eduardo R; Schlussman Stefan D; Ho Ann; Kreek Mary Jeanne
Effect of the kappa opioid agonist R-84760 on cocaine-induced increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice.
Psychopharmacology 2004;173(1-2):146-52.
2004: Zhang Yong; Butelman Eduardo R; Schlussman Stefan D; Ho Ann; Kreek Mary Jeanne
Effect of the endogenous kappa opioid agonist dynorphin A(1-17) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice.
Psychopharmacology 2004;172(4):422-9.
2004: Butelman Eduardo R; Ball Jonathan W; Kreek Mary-Jeanne
Peripheral selectivity and apparent efficacy of dynorphins: comparison to non-peptidic kappa-opioid agonists in rhesus monkeys.
Psychoneuroendocrinology 2004;29(3):307-26.
2004: LaForge K Steven; Nyberg Fred; Kreek Mary Jeanne
Primary structure of guinea pig preprodynorphin and preproenkephalin mRNAs: multiple transcription initiation sites for preprodynorphin.
Brain research bulletin 2004;63(2):119-26.
2004: Butelman Eduardo R; Harris Todd J; Kreek Mary Jeanne
The plant-derived hallucinogen, salvinorin A, produces kappa-opioid agonist-like discriminative effects in rhesus monkeys.
Psychopharmacology 2004;172(2):220-4.
2004: Kreek Mary Jeanne; Schlussman Stefan D; Bart Gavin; Laforge K Steven; Butelman Eduardo R
Evolving perspectives on neurobiological research on the addictions: celebration of the 30th anniversary of NIDA.
Neuropharmacology 2004;47 Suppl 1():324-44.
2004: Kreek Mary Jeanne; Nielsen David A; LaForge K Steven
Genes associated with addiction: alcoholism, opiate, and cocaine addiction.
Neuromolecular medicine 2004;5(1):85-108.
2003: Zhang Yong; Schlussman Stefan D; Ho Ann; Kreek Mary Jeanne
Effect of chronic "binge cocaine" on basal levels and cocaine-induced increases of dopamine in the caudate putamen and nucleus accumbens of C57BL/6J and 129/J mice.
Synapse (New York, N.Y.) 2003;50(3):191-9.
2003: Mantsch J R; Yuferov V; Mathieu-Kia A-M; Ho A; Kreek M J
Neuroendocrine alterations in a high-dose, extended-access rat self-administration model of escalating cocaine use.
Psychoneuroendocrinology 2003;28(7):836-62.
2003: Sinha Rajita; Talih Makram; Malison Robert; Cooney Ned; Anderson George M; Kreek Mary Jeanne
Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states.
Psychopharmacology 2003;170(1):62-72.
2003: Butelman Eduardo R; Ball Jonathan W; Harris Todd J; Kreek Mary Jeanne
Topical capsaicin-induced allodynia in unanesthetized primates: pharmacological modulation.
The Journal of pharmacology and experimental therapeutics 2003;306(3):1106-14.
2003: Reed Brian; Zhang Yong; Chait Brian T; Kreek Mary Jeanne
Dynorphin A(1-17) biotransformation in striatum of freely moving rats using microdialysis and matrix-assisted laser desorption/ionization mass spectrometry.
Journal of neurochemistry 2003;86(4):815-23.
2003: Bart Gavin; Borg Lisa; Schluger James H; Green Mark; Ho Ann; Kreek Mary Jeanne
Suppressed prolactin response to dynorphin A1-13 in methadone-maintained versus control subjects.
The Journal of pharmacology and experimental therapeutics 2003;306(2):581-7.
2003: Schlussman Stefan D; Zhang Yong; Yuferov Vadim; LaForge K Steven; Ho Ann; Kreek Mary Jeanne
Acute 'binge' cocaine administration elevates dynorphin mRNA in the caudate putamen of C57BL/6J but not 129/J mice.
Brain research 2003;974(1-2):249-53.
2003: Yuferov Vadim; Kroslak Thomas; Laforge K Steven; Zhou Yan; Ho Ann; Kreek Mary Jeanne
Differential gene expression in the rat caudate putamen after "binge" cocaine administration: advantage of triplicate microarray analysis.
Synapse (New York, N.Y.) 2003;48(4):157-69.
2003: Zhou Yan; Spangler Rudolph; Ho Ann; Kreek Mary Jeanne
Increased CRH mRNA levels in the rat amygdala during short-term withdrawal from chronic 'binge' cocaine.
Brain research. Molecular brain research 2003;114(1):73-9.
2003: Schluger James H; Bart Gavin; Green Mark; Ho Ann; Kreek Mary Jeanne
Corticotropin-releasing factor testing reveals a dose-dependent difference in methadone maintained vs control subjects.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(5):985-94.
2003: Schlussman Stefan D; Zhang Yong; Kane Saul; Stewart Campbell L; Ho Ann; Kreek Mary Jeanne
Locomotion, stereotypy, and dopamine D1 receptors after chronic "binge" cocaine in C57BL/6J and 129/J mice.
Pharmacology, biochemistry, and behavior 2003;75(1):123-31.
2003: Kellogg Scott H; McHugh Pauline F; Bell Kathy; Schluger James H; Schluger Rosemary P; LaForge K Steven; Ho Ann; Kreek Mary Jeanne
The Kreek-McHugh-Schluger-Kellogg scale: a new, rapid method for quantifying substance abuse and its possible applications.
Drug and alcohol dependence 2003;69(2):137-50.
2003: Kruzich P J; Chen A C H; Unterwald E M; Kreek M J
Subject-regulated dosing alters morphine self-administration behavior and morphine-stimulated [35S]GTPgammaS binding.
Synapse (New York, N.Y.) 2003;47(4):243-9.
2003: Kakko Johan; Svanborg Kerstin Dybrandt; Kreek Mary Jeanne; Heilig Markus
1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial.
Lancet 2003;361(9358):662-8.
2003: Proudnikov Dmitri; Yuferov Vadim; Zhou Yan; LaForge K Steven; Ho Ann; Kreek Mary Jeanne
Optimizing primer--probe design for fluorescent PCR.
Journal of neuroscience methods 2003;123(1):31-45.
2003: Zhou Yan; Spangler Rudolph; Schlussman Stefan D; Ho Ann; Kreek Mary Jeanne
Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
Brain research 2003;964(2):187-99.
2002: Butelman Eduardo R; Ball Jonathan W; Kreek Mary-Jeanne
Comparison of the discriminative and neuroendocrine effects of centrally penetrating kappa-opioid agonists in rhesus monkeys.
Psychopharmacology 2002;164(1):115-20.
2002: Zhang Yong; Mantsch John R; Schlussman Stefan D; Ho Ann; Kreek Mary Jeanne
Conditioned place preference after single doses or "binge" cocaine in C57BL/6J and 129/J mice.
Pharmacology, biochemistry, and behavior 2002;73(3):655-62.
2002: Kreek Mary Jeanne; Vocci Frank J
History and current status of opioid maintenance treatments: blending conference session.
Journal of substance abuse treatment 2002;23(2):93-105.
2002: Kreek Mary Jeanne; LaForge K Steven; Butelman Eduardo
Pharmacotherapy of addictions.
Nature reviews. Drug discovery 2002;1(9):710-26.
2002: Zhou Yan; Spangler Rudolph; Schlussman Stefan D; Yuferov Vadim P; Sora Ichiro; Ho Ann; Uhl George R; Kreek Mary Jeanne
Effects of acute "binge" cocaine on preprodynorphin, preproenkephalin, proopiomelanocortin, and corticotropin-releasing hormone receptor mRNA levels in the striatum and hypothalamic-pituitary-adrenal axis of mu-opioid receptor knockout mice.
Synapse (New York, N.Y.) 2002;45(4):220-9.
2002: Kellogg Scott H; Ho Ann; Bell Kathy; Schluger Rosemary P; McHugh Pauline F; McClary Kelly A; Kreek Mary Jeanne
The Personality Assessment Inventory Drug Problems Scale: a validity analysis.
Journal of personality assessment 2002;79(1):73-84.
2002: Mathieu-Kia A M; Kellogg S H; Butelman E R; Kreek M J
Nicotine addiction: insights from recent animal studies.
Psychopharmacology 2002;162(2):102-18.
2002: King Andrea C; Schluger James; Gunduz Mithat; Borg Lisa; Perret Guillaume; Ho Ann; Kreek Mary Jeanne
Hypothalamic-pituitary-adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;26(6):778-88.
2002: Chen Andrew C H; LaForge K Steven; Ho Ann; McHugh Pauline F; Kellogg Scott; Bell Kathy; Schluger Rosemary P; Leal Suzanne M; Kreek Mary Jeanne
Potentially functional polymorphism in the promoter region of prodynorphin gene may be associated with protection against cocaine dependence or abuse.
American journal of medical genetics 2002;114(4):429-35.
2002: O'Malley Stephanie S; Krishnan-Sarin Suchitra; Farren Conor; Sinha Rajita; Kreek Mary Jeanne
Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.
Psychopharmacology 2002;160(1):19-29.
2002: Piccolo Paola; Borg Lisa; Lin Amy; Melia Dorothy; Ho Ann; Kreek Mary Jeanne
Hepatitis C virus and human immunodeficiency virus-1 co-infection in former heroin addicts in methadone maintenance treatment.
Journal of addictive diseases 2002;21(4):55-66.
2002: Borg Lisa; Ho Ann; Wells Aaron; Joseph Herman; Appel Phil; Moody David; Kreek Mary Jeanne
The use of levo-alpha-acetylmethadol (LAAM) in methadone patients who have not achieved heroin abstinence.
Journal of addictive diseases 2002;21(3):13-22.
2001: Zhang Y; Schlussman S D; Ho A; Kreek M J
Effect of acute binge cocaine on levels of extracellular dopamine in the caudate putamen and nucleus accumbens in male C57BL/6J and 129/J mice.
Brain research 2001;923(1-2):172-7.
2001: Zhou Y; Unterwald E M; Ho A; LaForge K S; Yuferov V P; Kreuter J; Sirianni M J; Allen R G; Kreek M J
Ablation of pituitary pro-opiomelanocortin (POMC) cells produces alterations in hypothalamic POMC mRNA levels and midbrain mu opioid receptor binding in a conditional transgenic mouse model.
Journal of neuroendocrinology 2001;13(9):808-17.
2001: Butelman E R; Ko M C; Traynor J R; Vivian J A; Kreek M J; Woods J H
GR89,696: a potent kappa-opioid agonist with subtype selectivity in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 2001;298(3):1049-59.
2001: Mantsch J R; Ho A; Schlussman S D; Kreek M J
Predictable individual differences in the initiation of cocaine self-administration by rats under extended-access conditions are dose-dependent.
Psychopharmacology 2001;157(1):31-9.
2001: Cigler T; LaForge K S; McHugh P F; Kapadia S U; Leal S M; Kreek M J
Novel and previously reported single-nucleotide polymorphisms in the human 5-HT(1B) receptor gene: no association with cocaine or alcohol abuse or dependence.
American journal of medical genetics 2001;105(6):489-97.
2001: Butelman E R; Kreek M J
kappa-Opioid receptor agonist-induced prolactin release in primates is blocked by dopamine D(2)-like receptor agonists.
European journal of pharmacology 2001;423(2-3):243-9.
2001: Kreek M J
Drug addictions. Molecular and cellular endpoints.
Annals of the New York Academy of Sciences 2001;937():27-49.
2001: Yuferov V; Zhou Y; LaForge K S; Spangler R; Ho A; Kreek M J
Elevation of guinea pig brain preprodynorphin mRNA expression and hypothalamic-pituitary-adrenal axis activity by "binge" pattern cocaine administration.
Brain research bulletin 2001;55(1):65-70.
2001: Schluger J H; Borg L; Ho A; Kreek M J
Altered HPA axis responsivity to metyrapone testing in methadone maintained former heroin addicts with ongoing cocaine addiction.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;24(5):568-75.
2001: Mathieu-Kia A M; Fan L Q; Kreek M J; Simon E J; Hiller J M
Mu-, delta- and kappa-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer's disease patients.
Brain research 2001;893(1-2):121-34.
2001: Jacobsen L K; Giedd J N; Kreek M J; Gottschalk C; Kosten T R
Quantitative medial temporal lobe brain morphology and hypothalamic-pituitary-adrenal axis function in cocaine dependence: a preliminary report.
Drug and alcohol dependence 2001;62(1):49-56.
2000: LaForge K S; Yuferov V; Kreek M J
Opioid receptor and peptide gene polymorphisms: potential implications for addictions.
European journal of pharmacology 2000;410(2-3):249-268.
2000: Kling M A; Carson R E; Borg L; Zametkin A; Matochik J A; Schluger J; Herscovitch P; Rice K C; Ho A; Eckelman W C; Kreek M J
Opioid receptor imaging with positron emission tomography and [(18)F]cyclofoxy in long-term, methadone-treated former heroin addicts.
The Journal of pharmacology and experimental therapeutics 2000;295(3):1070-6.
2000: Quiñones-Jenab V; Perrotti L I; Mc Monagle J; Ho A; Kreek M J
Ovarian hormone replacement affects cocaine-induced behaviors in ovariectomized female rats.
Pharmacology, biochemistry, and behavior 2000;67(3):417-22.
2000: LaForge K S; Shick V; Spangler R; Proudnikov D; Yuferov V; Lysov Y; Mirzabekov A; Kreek M J
Detection of single nucleotide polymorphisms of the human mu opioid receptor gene by hybridization or single nucleotide extension on custom oligonucleotide gelpad microchips: potential in studies of addiction.
American journal of medical genetics 2000;96(5):604-15.
2000: Zhou Y; Franck J; Spangler R; Maggos C E; Ho A; Kreek M J
Reduced hypothalamic POMC and anterior pituitary CRF1 receptor mRNA levels after acute, but not chronic, daily "binge" intragastric alcohol administration.
Alcoholism, clinical and experimental research 2000;24(10):1575-82.
2000: Mantsch J R; Schlussman S D; Ho A; Kreek M J
Effects of cocaine self-administration on plasma corticosterone and prolactin in rats.
The Journal of pharmacology and experimental therapeutics 2000;294(1):239-47.
2000: Quiñones-Jenab V; Perrotti L I; Ho A; Jenab S; Schlussman S D; Franck J; Kreek M J
Cocaine affects progesterone plasma levels in female rats.
Pharmacology, biochemistry, and behavior 2000;66(2):449-53.
2000: Schlussman S D; Zhou Y; Johansson P; Kiuru A; Ho A; Nyberg F; Kreek M J
Effects of the androgenic anabolic steroid, nandrolone decanoate, on adrenocorticotropin hormone, corticosterone and proopiomelanocortin, corticotropin releasing factor (CRF) and CRF receptor1 mRNA levels in the hypothalamus, pituitary and amygdala of the rat.
Neuroscience letters 2000;284(3):190-4.
2000: Quiñones-Jenab V; Krey L C; Schlussman S D; Ho A; Kreek M J
Chronic 'binge' pattern cocaine alters the neuroendocrine profile of pregnant rats.
Neuroscience letters 2000;282(1-2):120-2.
2000: Kreek M J
Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine.
Annals of the New York Academy of Sciences 2000;909():186-216.
1999: Butelman E R; Harris T J; Kreek M
Apparent efficacy of kappa-opioid receptor ligands on serum prolactin levels in rhesus monkeys.
European journal of pharmacology 1999;383(3):305-9.
1999: Butelman E R; Harris T J; Kreek M J
Effects of E-2078, a stable dynorphin A(1-8) analog, on sedation and serum prolactin levels in rhesus monkeys.
Psychopharmacology 1999;147(1):73-80.
1999: Zhou Y; Spangler R; Maggos C E; Wang X M; Han J S; Ho A; Kreek M J
Hypothalamic-pituitary-adrenal activity and pro-opiomelanocortin mRNA levels in the hypothalamus and pituitary of the rat are differentially modulated by acute intermittent morphine with or without water restriction stress.
The Journal of endocrinology 1999;163(2):261-7.
1999: Zhou Y; Schlussman S D; Ho A; Spangler R; Fienberg A A; Greengard P; Kreek M J
Effects of chronic 'Binge' cocaine administration on plasma ACTH and corticosterone levels in mice deficient in DARPP-32.
Neuroendocrinology 1999;70(3):196-9.
1999: Butelman E R; Harris T J; Perez A; Kreek M J
Effects of systemically administered dynorphin A(1-17) in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1999;290(2):678-86.
1999: Quiñones-Jenab V; Ho A; Schlussman S D; Franck J; Kreek M J
Estrous cycle differences in cocaine-induced stereotypic and locomotor behaviors in Fischer rats.
Behavioural brain research 1999;101(1):15-20.
1999: Borg L; Khuri E; Wells A; Melia D; Bergasa N V; Ho A; Kreek M J
Methadone-maintained former heroin addicts, including those who are anti-HIV-1 seropositive, comply with and respond to hepatitis B vaccination.
Addiction (Abingdon, England) 1999;94(4):489-93.
1999: Butelman E R; Vivian J A; Yu J; Kreek M J; Woods J H
Systemic effects of E-2078, a stabilized dynorphin A(1-8) analog, in rhesus monkeys.
Psychopharmacology 1999;143(2):190-6.
1999: Farren C K; O'Malley S; Grebski G; Maniar S; Porter M; Kreek M J
Variable dose naltrexone-induced hypothalamic-pituitary-adrenal stimulation in abstinent alcoholics: a preliminary study.
Alcoholism, clinical and experimental research 1999;23(3):502-8.
1999: King A C; Ho A; Schluger J; Borg L; Kreek M J
Acute subjective effects of dynorphin A(1-13) infusion in normal healthy subjects.
Drug and alcohol dependence 1999;54(1):87-90.
1999: Wang X M; Zhou Y; Spangler R; Ho A; Han J S; Kreek M J
Acute intermittent morphine increases preprodynorphin and kappa opioid receptor mRNA levels in the rat brain.
Brain research. Molecular brain research 1999;66(1-2):184-7.
1999: Yuferov V; Zhou Y; Spangler R; Maggos C E; Ho A; Kreek M J
Acute "binge" cocaine increases mu-opioid receptor mRNA levels in areas of the rat mesolimbic mesocortical dopamine system.
Brain research bulletin 1999;48(1):109-12.
1999: Kreek M J; Schluger J; Borg L; Gunduz M; Ho A
Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
The Journal of pharmacology and experimental therapeutics 1999;288(1):260-9.
1999: Borg L; Broe D M; Ho A; Kreek M J
Cocaine abuse sharply reduced in an effective methadone maintenance program.
Journal of addictive diseases 1999;18(4):63-75.
1998: Bodner G; Ho A; Kreek M J
Effect of endogenous cortisol levels on natural killer cell activity in healthy humans.
Brain, behavior, and immunity 1998;12(4):285-96.
1998: Sarnyai Z; Dhabhar F S; McEwen B S; Kreek M J
Neuroendocrine-related effects of long-term, 'binge' cocaine administration: diminished individual differences in stress-induced corticosterone response.
Neuroendocrinology 1998;68(5):334-44.
1998: Sarnyai Z; McKittrick C R; McEwen B S; Kreek M J
Selective regulation of dopamine transporter binding in the shell of the nucleus accumbens by adrenalectomy and corticosterone-replacement.
Synapse (New York, N.Y.) 1998;30(3):334-7.
1998: Schluger J H; Ho A; Borg L; Porter M; Maniar S; Gunduz M; Perret G; King A; Kreek M J
Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism.
Alcoholism, clinical and experimental research 1998;22(7):1430-6.
1998: Perret G; Schluger J H; Unterwald E M; Kreuter J; Ho A; Kreek M J
Downregulation of 5-HT1A receptors in rat hypothalamus and dentate gyrus after "binge" pattern cocaine administration.
Synapse (New York, N.Y.) 1998;30(2):166-71.
1998: Bond C; LaForge K S; Tian M; Melia D; Zhang S; Borg L; Gong J; Schluger J; Strong J A; Leal S M; Tischfield J A; Kreek M J; Yu L
Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(16):9608-13.
1998: Maggos C E; Tsukada H; Kakiuchi T; Nishiyama S; Myers J E; Kreuter J; Schlussman S D; Unterwald E M; Ho A; Kreek M J
Sustained withdrawal allows normalization of in vivo [11C]N-methylspiperone dopamine D2 receptor binding after chronic binge cocaine: a positron emission tomography study in rats.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1998;19(2):146-53.
1998: Zhou Y; Yuferov V P; Spangler R; Maggos C E; Ho A; Kreek M J
Effects of memantine alone and with acute 'binge' cocaine on hypothalamic-pituitary-adrenal activity in the rat.
European journal of pharmacology 1998;352(1):65-71.
1998: Kreek M J; Koob G F
Drug dependence: stress and dysregulation of brain reward pathways.
Drug and alcohol dependence 1998;51(1-2):23-47.
1998: Schlussman S D; Ho A; Zhou Y; Curtis A E; Kreek M J
Effects of "binge" pattern cocaine on stereotypy and locomotor activity in C57BL/6J and 129/J mice.
Pharmacology, biochemistry, and behavior 1998;60(2):593-9.
1998: Yuferov V P; Culpepper-Morgan J A; LaForge K S; Ho A; Kreek M J
Regional quantitation of preprodynorphin mRNA in guinea pig gastrointestinal tract.
Neurochemical research 1998;23(4):505-11.
1998: Mason B J; Kocsis J H; Melia D; Khuri E T; Sweeney J; Wells A; Borg L; Millman R B; Kreek M J
Psychiatric comorbidity in methadone maintained patients.
Journal of addictive diseases 1998;17(3):75-89.
1997: Quiñones-Jenab V; Batel P; Schlussman S D; Ho A; Kreek M J
Cocaine impairs maternal nest building in pregnant rats.
Pharmacology, biochemistry, and behavior 1997;58(4):1009-13.
1997: Unterwald E M; Tsukada H; Kakiuchi T; Kosugi T; Nishiyama S; Kreek M J
Use of positron emission tomography to measure the effects of nalmefene on D1 and D2 dopamine receptors in rat brain.
Brain research 1997;775(1-2):183-8.
1997: Lucas L R; Schlussman S D; Ho A; McEwen B S; Kreek M J
Novelty-induced locomoter activity in Long-Evans rats pre- and post-chronic 'binge'-pattern cocaine treatment.
Neuroscience letters 1997;237(1):25-8.
1997: King A C; Volpicelli J R; Gunduz M; O'Brien C P; Kreek M J
Naltrexone biotransformation and incidence of subjective side effects: a preliminary study.
Alcoholism, clinical and experimental research 1997;21(5):906-9.
1997: Yu J; Butelman E R; Woods J H; Chait B T; Kreek M J
Dynorphin A (1-8) analog, E-2078, crosses the blood-brain barrier in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1997;282(2):633-8.
1997: Kreek M J
Opiate and cocaine addictions: challenge for pharmacotherapies.
Pharmacology, biochemistry, and behavior 1997;57(3):551-69.
1997: Spangler R; Zhou Y; Schlussman S D; Ho A; Kreek M J
Behavioral stereotypies induced by "binge' cocaine administration are independent of drug-induced increases in corticosterone levels.
Behavioural brain research 1997;86(2):201-4.
1997: LaForge K S; Ho A; Kreek M J
Distribution and polysome association of full-length and 3' truncated preproenkephalin mRNA in the guinea-pig brain.
Brain research. Molecular brain research 1997;46(1-2):169-76.
1997: Maggos C E; Spangler R; Zhou Y; Schlussman S D; Ho A; Kreek M J
Quantitation of dopamine transporter mRNA in the rat brain: mapping, effects of "binge" cocaine administration and withdrawal.
Synapse (New York, N.Y.) 1997;26(1):55-61.
1997: Yu J; Butelman E R; Woods J H; Chait B T; Kreek M J
Dynorphin A (1-8) analog, E-2078, is stable in human and rhesus monkey blood.
The Journal of pharmacology and experimental therapeutics 1997;280(3):1147-51.
1997: Novick D M; Reagan K J; Croxson T S; Gelb A M; Stenger R J; Kreek M J
Hepatitis C virus serology in parenteral drug users with chronic liver disease.
Addiction (Abingdon, England) 1997;92(2):167-71.
1997: Culpepper-Morgan J A; Kreek M J
Hypothalamic-pituitary-adrenal axis hypersensitivity to naloxone in opioid dependence: a case of naloxone-induced withdrawal.
Metabolism: clinical and experimental 1997;46(2):130-4.
1997: Spangler R; Zhou Y; Maggos C E; Schlussman S D; Ho A; Kreek M J
Prodynorphin, proenkephalin and kappa opioid receptor mRNA responses to acute "binge" cocaine.
Brain research. Molecular brain research 1997;44(1):139-42.
1997: Kreek M J
Goals and rationale for pharmacotherapeutic approach in treating cocaine dependence: insights from basic and clinical research.
NIDA research monograph 1997;175():5-35.
1997: Bergasa N V; Mohajer B; Maisonneuve I M; Ho A; Maidment N T; Olive F; Gunduz M; Kreek M J
Basal total opioid peptide release in the striatum of rats with cholestasis from bile duct resection: a study by the use of in vivo microdialysis.
Life sciences 1997;61(12):1169-75.
1996: Yuferov V P; Laforge K S; Spangler R; Maggos C E; Kreek M J
Guinea pig preprodynorphin mRNA: primary structure and regional quantitation in the brain.
DNA and cell biology 1996;15(12):1105-12.
1996: Tsukada H; Kreuter J; Maggos C E; Unterwald E M; Kakiuchi T; Nishiyama S; Futatsubashi M; Kreek M J
Effects of binge pattern cocaine administration on dopamine D1 and D2 receptors in the rat brain: an in vivo study using positron emission tomography.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1996;16(23):7670-7.
1996: Peters J E; Chou J Z; Ho A; Reid K; Borg L; Kreek M J
Simplified quantitation of urinary benzoylecgonine in cocaine addiction research and for related pharmacotherapeutic trials.
Addiction (Abingdon, England) 1996;91(11):1687-97.
1996: Zhou Y; Spangler R; Maggos C E; LaForge K S; Ho A; Kreek M J
Steady-state methadone in rats does not change mRNA levels of corticotropin-releasing factor, its pituitary receptor or proopiomelanocortin.
European journal of pharmacology 1996;315(1):31-5.
1996: Kreek M J
Opioid receptors: some perspectives from early studies of their role in normal physiology, stress responsivity, and in specific addictive diseases.
Neurochemical research 1996;21(11):1469-88.
1996: Yu J; Butelman E R; Woods J H; Chait B T; Kreek M J
In vitro biotransformation of dynorphin A (1-17) is similar in human and rhesus monkey blood as studied by matrix-assisted laser desorption/ionization mass spectrometry.
The Journal of pharmacology and experimental therapeutics 1996;279(2):507-14.
1996: Zhou Y; Spangler R; LaForge K S; Maggos C E; Ho A; Kreek M J
Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and chronic withdrawal.
The Journal of pharmacology and experimental therapeutics 1996;279(1):351-8.
1996: Spangler R; Zhou Y; Maggos C E; Zlobin A; Ho A; Kreek M J
Dopamine antagonist and "binge' cocaine effects on rat opioid and dopamine transporter mRNAs.
Neuroreport 1996;7(13):2196-200.
1996: Spangler R; Ho A; Zhou Y; Maggos C E; Yuferov V; Kreek M J
Regulation of kappa opioid receptor mRNA in the rat brain by "binge' pattern cocaine administration and correlation with preprodynorphin mRNA.
Brain research. Molecular brain research 1996;38(1):71-6.
1996: Claye L H; Unterwald E M; Ho A; Kreek M J
Both dynorphin A(1-17) [Des-Tyr1]dynorphin A(2-17) inhibit adenylyl cyclase activity in rat caudate putamen.
The Journal of pharmacology and experimental therapeutics 1996;277(1):359-65.
1996: Kreek M J
Cocaine, dopamine and the endogenous opioid system.
Journal of addictive diseases 1996;15(4):73-96.
1996: Chou J Z; Chait B T; Wang R; Kreek M J
Differential biotransformation of dynorphin A (1-17) and dynorphin A (1-13) peptides in human blood, ex vivo.
Peptides 1996;17(6):983-90.
1996: Yu J; Chait B T; Toll L; Kreek M J
Nociceptin in vitro biotransformation in human blood.
Peptides 1996;17(5):873-6.
1996: Zhou Y; Spangler R; LaForge K S; Maggos C E; Ho A; Kreek M J
Modulation of CRF-R1 mRNA in rat anterior pituitary by dexamethasone: correlation with POMC mRNA.
Peptides 1996;17(3):435-41.
1995: Unterwald E M; Rubenfeld J M; Imai Y; Wang J B; Uhl G R; Kreek M J
Chronic opioid antagonist administration upregulates mu opioid receptor binding without altering mu opioid receptor mRNA levels.
Brain research. Molecular brain research 1995;33(2):351-5.
1995: LaForge K S; Unterwald E M; Kreek M J
Structure and expression of the guinea pig preproenkephalin gene: site-specific cleavage in the 3' untranslated region yields truncated mRNA transcripts in specific brain regions.
Molecular and cellular biology 1995;15(4):2080-9.
1995: Maisonneuve I M; Ho A; Kreek M J
Chronic administration of a cocaine "binge" alters basal extracellular levels in male rats: an in vivo microdialysis study.
The Journal of pharmacology and experimental therapeutics 1995;272(2):652-7.
1995: Borg L; Ho A; Peters J E; Kreek M J
Availability of reliable serum methadone determination for management of symptomatic patients.
Journal of addictive diseases 1995;14(3):83-96.
1995: Culpepper-Morgan J A; Holt P R; LaRoche D; Kreek M J
Orally administered opioid antagonists reverse both mu and kappa opioid agonist delay of gastrointestinal transit in the guinea pig.
Life sciences 1995;56(14):1187-92.
1994: Ochshorn-Adelson M; Bodner G; Toraker P; Albeck H; Ho A; Kreek M J
Effects of ethanol on human natural killer cell activity: in vitro and acute, low-dose in vivo studies.
Alcoholism, clinical and experimental research 1994;18(6):1361-7.
1994: Kreek M J
Biological correlates of methadone maintenance pharmacotherapy.
Annales de médecine interne 1994;145 Suppl 3():9-14.
1994: Adelson M O; Novick D M; Khuri E; Albeck H; Hahn E F; Kreek M J
Effects of the opioid antagonist naloxone on human natural killer cell activity in vitro.
Israel journal of medical sciences 1994;30(9):679-84.
1994: Unterwald E M; Ho A; Rubenfeld J M; Kreek M J
Time course of the development of behavioral sensitization and dopamine receptor up-regulation during binge cocaine administration.
The Journal of pharmacology and experimental therapeutics 1994;270(3):1387-96.
1994: Unterwald E M; Rubenfeld J M; Kreek M J
Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors.
Neuroreport 1994;5(13):1613-6.
1994: Maisonneuve I M; Kreek M J
Acute tolerance to the dopamine response induced by a binge pattern of cocaine administration in male rats: an in vivo microdialysis study.
The Journal of pharmacology and experimental therapeutics 1994;268(2):916-21.
1993: Novick D M; Richman B L; Friedman J M; Friedman J E; Fried C; Wilson J P; Townley A; Kreek M J
The medical status of methadone maintenance patients in treatment for 11-18 years.
Drug and alcohol dependence 1993;33(3):235-45.
1993: Unterwald E M; Cox B M; Kreek M J; Cote T E; Izenwasser S
Chronic repeated cocaine administration alters basal and opioid-regulated adenylyl cyclase activity.
Synapse (New York, N.Y.) 1993;15(1):33-8.
1993: Spangler R; Unterwald E M; Kreek M J
'Binge' cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen.
Brain research. Molecular brain research 1993;19(4):323-7.
1993: Chou J Z; Albeck H; Kreek M J
Determination of nalmefene in plasma by high-performance liquid chromatography with electrochemical detection and its application in pharmacokinetic studies.
Journal of chromatography 1993;613(2):359-64.
1992: Culpepper-Morgan J A; Inturrisi C E; Portenoy R K; Foley K; Houde R W; Marsh F; Kreek M J
Treatment of opioid-induced constipation with oral naloxone: a pilot study.
Clinical pharmacology and therapeutics 1992;52(1):90-5.
1992: Unterwald E M; Horne-King J; Kreek M J
Chronic cocaine alters brain mu opioid receptors.
Brain research 1992;584(1-2):314-8.
1992: Branch A D; Unterwald E M; Lee S E; Kreek M J
Quantitation of preproenkephalin mRNA levels in brain regions from male Fischer rats following chronic cocaine treatment using a recently developed solution hybridization assay.
Brain research. Molecular brain research 1992;14(3):231-8.
1992: Kreek M J
Effects of opiates, opioid antagonists and cocaine on the endogenous opioid system: clinical and laboratory studies.
NIDA research monograph 1992;119():44-8.
1992: Kreek M J
Effects of drugs of abuse and treatment agents in women.
NIDA research monograph 1992;119():106-10.
1992: Kreek M J
Rationale for maintenance pharmacotherapy of opiate dependence.
Research publications - Association for Research in Nervous and Mental Disease 1992;70():205-30.
1991: Novick D M; Ochshorn M; Kreek M J
In vivo and in vitro studies of opiates and cellular immunity in narcotic addicts.
Advances in experimental medicine and biology 1991;288():159-70.
1991: Kreek M J
Using methadone effectively: achieving goals by application of laboratory, clinical, and evaluation research and by development of innovative programs.
NIDA research monograph 1991;106():245-66.
1990: Tabasco-Minguillan J; Novick D M; Kreek M J
Liver function tests in non-parenteral cocaine users.
Drug and alcohol dependence 1990;26(2):169-74.
1990: Kennedy J A; Hartman N; Sbriglio R; Khuri E; Kreek M J
Metyrapone-induced withdrawal symptoms.
British journal of addiction 1990;85(9):1133-40.
1990: Ochshorn M; Novick D M; Kreek M J
In vitro studies of the effect of methadone on natural killer cell activity.
Israel journal of medical sciences 1990;26(8):421-5.
1990: Kreek M J; Des Jarlais D C; Trepo C L; Novick D M; Abdul-Quader A; Raghunath J
Contrasting prevalence of delta hepatitis markers in parenteral drug abusers with and without AIDS.
The Journal of infectious diseases 1990;162(2):538-41.
1990: Piccione P R; Holt P R; Culpepper-Morgan J A; Paris P; O'Bryan L; Ferdinands L; Kreek M J
Intestinal dysmotility syndromes in the elderly: measurement of orocecal transit time.
The American journal of gastroenterology 1990;85(2):161-4.
1990: Kreek M J; Khuri E; Flomenberg N; Albeck H; Ochshorn M
Immune status of unselected methadone maintained former heroin addicts.
Progress in clinical and biological research 1990;328():445-8.
1990: Kreek M J
Immune function in heroin addicts and former heroin addicts in treatment: pre- and post-AIDS epidemic.
NIDA research monograph 1990;96():192-219.
1990: Kennedy J A; Hartman N; Sbriglio R; Khuri E; Albeck H; Kreek M J
Metyrapone-induced withdrawal symptoms: symptoms in methadone-maintained patients.
NIDA research monograph 1990;105():416.
1990: Bodner G; Soda K M; Kennedy J; Albeck H; Kreek M J
Modulation of NK activity: role of neuroendocrine status.
NIDA research monograph 1990;105():412-3.
1990: Unterwald E M; Nyberg F; Terenius L; Kreek M J
Distribution of opioid peptides in brain and GI tract: age- and species-specific differences.
NIDA research monograph 1990;105():408-9.
1990: Tabasco-Minguillan J; Novick D M; Kreek M J
Liver function tests in non-parenteral cocaine users.
NIDA research monograph 1990;105():372.
1990: Kreek M J; Culpepper-Morgan J
Neuroendocrine (HPA) and gastrointestinal effects of opiate antagonists: possible therapeutic application.
NIDA research monograph 1990;105():168-74.
1989: Novick D M; Trigg H L; Des Jarlais D C; Friedman S R; Vlahov D; Kreek M J
Cocaine injection and ethnicity in parenteral drug users during the early years of the human immunodeficiency virus (HIV) epidemic in New York City.
Journal of medical virology 1989;29(3):181-5.
1989: Novick D M; Ochshorn M; Ghali V; Croxson T S; Mercer W D; Chiorazzi N; Kreek M J
Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients.
The Journal of pharmacology and experimental therapeutics 1989;250(2):606-10.
1989: Albeck H; Woodfield S; Kreek M J
Quantitative and pharmacokinetic analysis of naloxone in plasma using high-performance liquid chromatography with electrochemical detection and solid-phase extraction.
Journal of chromatography 1989;488(2):435-45.
1989: Ochshorn M; Bodner G; Novick D M; Kreek M J
The effect of methadone in vitro on natural killer (NK) activity.
NIDA research monograph 1989;95():522-3.
1988: Novick D M; Farci P; Croxson T S; Taylor M B; Schneebaum C W; Lai M E; Bach N; Senie R T; Gelb A M; Kreek M J
Hepatitis D virus and human immunodeficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive.
The Journal of infectious diseases 1988;158(4):795-803.
1988: Novick D M; Des Jarlais D C; Kreek M J; Spira T J; Friedman S R; Gelb A M; Stenger R J; Schable C A; Kalyanaraman V S
Specificity of antibody tests for human immunodeficiency virus in alcohol and parenteral drug abusers with chronic liver disease.
Alcoholism, clinical and experimental research 1988;12(5):687-90.
1988: Kreek M J
Opiate-ethanol interactions: implications for the biological basis and treatment of combined addictive diseases.
NIDA research monograph 1988;81():428-39.
1988: Culpepper-Morgan J; Kreek M J; Holt P R; LaRoche D; Zhang J; O'Bryan L
Orally administered kappa as well as mu opiate agonists delay gastrointestinal transit time in the guinea pig.
Life sciences 1988;42(21):2073-7.
1987: Novick D M; Senie R T; Kreek M J; Yancovitz S R
Clinical and demographic features of patients admitted to a new chemical dependency program in New York City.
Drug and alcohol dependence 1987;20(3):271-8.
1987: Kreek M J
Tolerance and dependence: implications for the pharmacological treatment of addiction.
NIDA research monograph 1987;76():53-62.
1986: Novick D M; Stenger R J; Gelb A M; Most J; Yancovitz S R; Kreek M J
Chronic liver disease in abusers of alcohol and parenteral drugs: a report of 204 consecutive biopsy-proven cases.
Alcoholism, clinical and experimental research 1986;10(5):500-5.
1986: Novick D M; Kreek M J; Des Jarlais D C; Spira T J; Khuri E T; Ragunath J; Kalyanaraman V S; Gelb A M; Miescher A
Antibody to LAV, the putative agent of AIDS, in parenteral drug abusers and methadone-maintained patients: therapeutic, historical, and ethical aspects.
NIDA research monograph 1986;67():318-20.
1986: Kreek M J; Khuri E; Fahey L; Miescher A; Arns P; Spagnoli D; Craig J; Millman R; Harte E H
Long-term followup studies of the medical status of adolescent former heroin addicts in chronic methadone maintenance treatment: liver disease and immune status.
NIDA research monograph 1986;67():307-9.
1985: Novick D M; Kreek M J; Arns P A; Lau L L; Yancovitz S R; Gelb A M
Effect of severe alcoholic liver disease on the disposition of methadone in maintenance patients.
Alcoholism, clinical and experimental research 1985;9(4):349-54.
1985: Novick D M; Farci P; Karayiannis P; Gelb A M; Stenger R J; Kreek M J; Thomas H C
Hepatitis D virus antibody in HBsAg-positive and HBsAg-negative substance abusers with chronic liver disease.
Journal of medical virology 1985;15(4):351-6.
1985: Novick D M; Enlow R W; Gelb A M; Stenger R J; Fotino M; Winter J W; Yancovitz S R; Schoenberg M D; Kreek M J
Hepatic cirrhosis in young adults: association with adolescent onset of alcohol and parenteral heroin abuse.
Gut 1985;26(1):8-13.
1984: Khuri E T; Millman R B; Hartman N; Kreek M J
Clinical issues concerning alcoholic youthful narcotic abusers.
Advances in alcohol & substance abuse 1984;3(4):69-86.
1983: Hartman N; Kreek M J; Ross A; Khuri E; Millman R B; Rodriguez R
Alcohol use in youthful methadone-maintained former heroin addicts: liver impairment and treatment outcome.
Alcoholism, clinical and experimental research 1983;7(3):316-20.
1981: Novick D M; Kreek M J; Fanizza A M; Yancovitz S R; Gelb A M; Stenger R J
Methadone disposition in patients with chronic liver disease.
Clinical pharmacology and therapeutics 1981;30(3):353-62.
1981: Novick D M; Gelb A M; Stenger R J; Yancovitz S R; Adelsberg B; Chateau F; Kreek M J
Hepatitis B serologic studies in narcotic users with chronic liver disease.
The American journal of gastroenterology 1981;75(2):111-5.

Sign-in to see more